Skip to main content

Table 2 clinical variables during treatment in two groups

From: Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study

Variable T0 T24 T48 T72 T96
SOFA
 Intervention 12.45 ± 2.65 10.27 ± 2.60 7.1 ± 1.92 3.72 ± 1.75 1.62 ± 1.19
 Control 10.7 ± 2.70 8.8 ± 2.65 7.92 ± 2.81 4.85 ± 2.51 3.10 ± 1.61
P value < 0.001 0.01 0.93 0.01 < 0.001
PCT
 Intervention 37.25 ± 20.93 26.50 ± 15.30 11.10 ± 6.04 4.02 ± 2.34 1.36 ± 0.79
 Control 45.28 ± 28.60 28.07 ± 17.48 16.27 ± 11.71 7.72 ± 7.29 2.82 ± 1.39
P value 0.15 0.67 0.01 < 0.001 < 0.001
CRP
 Intervention 27.40 ± 11.66 36.60 ± 13.85 14.97 ± 7.31 6.70 ± 3.61 2.30 ± 0.66
 Control 24.27 ± 12.83 45.1 ± 19.50 24.32 ± 12.72 11.47 ± 7.51 4.79 ± 1.78
P value 0.25 0.02 < 0.001 < 0.001 < 0.001
Pao2/Fio2
 Intervention 116.42 ± 27.60 191.49 ± 25.60 224.62 ± 23.40 262.87 ± 30.59 292.65 ± 29.42
 Control 160.51 ± 29.70 188.21 ± 26.61 208.50 ± 28.88 229.95 ± 33.10 257.20 ± 33.73
P value 0.99 0.6 < 0.001 < 0.001 < 0.001
Vitamin C
 Intervention 20.63 ± 12.74     79.20 ± 26.42
 Control 22.77 ± 13.56     16.38 ± 10.33
P value 0.47     < 0.001
  1. SOFA Sequential organ failure assessment
  2. PCT Procalcitonin (microgram per liter)
  3. CRP C reactive protein (milligram per liter)
  4. VIT C (milligram per liter)